
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | -- | -- | -- | -- | -- |
08/08/2025 | Q2 | -- | -- | -- | -- | -- |
05/12/2025 | Q1 | -- | -- | -$0.21 | -- | -- |
03/31/2025 | Q4 | -- | -- | -$0.02 | -- | -- |
11/14/2024 | Q3 | -- | -- | $0.31 | -- | -- |
08/08/2024 | Q2 | -- | -- | -$0.13 | -- | -- |
05/14/2024 | Q1 | -- | -- | -$0.19 | -- | -- |
03/26/2024 | Q4 | -- | -- | -$0.19 | -- | -- |
11/14/2023 | Q3 | -- | -- | -$0.19 | -- | -- |
08/14/2023 | Q2 | -- | -- | -$0.27 | -- | -- |
05/15/2023 | Q1 | -- | -- | -$0.58 | -- | -- |
03/08/2023 | Q4 | -- | -- | -$0.91 | -- | -- |
11/14/2022 | Q3 | -- | -- | -$0.83 | -- | -- |
08/15/2022 | Q2 | -- | -- | -$0.38 | -- | -- |
03/31/2022 | Q1 | -- | -- | -$0.29 | -- | -- |
12/31/2021 | Q4 | -- | -- | -$0.25 | -- | -- |
09/30/2021 | Q3 | -- | -- | -$0.20 | -- | -- |
06/30/2021 | Q2 | -- | -- | -$0.04 | -- | -- |
03/31/2021 | Q1 | -- | -- | -$1.43 | -- | -- |
12/31/2020 | Q4 | -- | $50 | -$0.04 | -- | -- |
09/30/2020 | Q3 | -- | -- | -$0.45 | -- | -- |
06/30/2020 | Q2 | -- | $1.2K | -$0.44 | -- | -- |
03/31/2020 | Q1 | -- | -- | -$0.42 | -- | -- |
12/31/2019 | Q4 | -- | $890 | -$0.47 | -- | -- |
09/30/2019 | Q3 | -- | $10 | -$0.45 | -- | -- |
06/30/2019 | Q2 | -- | -- | -$0.46 | -- | -- |
03/31/2019 | Q1 | -- | -- | -$0.45 | -- | -- |
12/31/2018 | Q4 | -- | $140 | -$0.37 | -- | -- |
09/30/2018 | Q3 | -- | $200 | -$0.46 | -- | -- |
06/30/2018 | Q2 | -- | -- | -$0.46 | -- | -- |
03/31/2018 | Q1 | -- | -- | -$0.46 | -- | -- |
12/31/2017 | Q4 | -- | $80 | -$0.46 | -- | -- |
09/30/2017 | Q3 | -- | $7.3K | -$0.48 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$0.46 | -- | -- |
03/31/2017 | Q1 | -- | $490 | -$0.45 | -- | -- |
12/31/2016 | Q4 | -- | $110 | -$0.44 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.22 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.20 | -- | -- |
03/31/2016 | Q1 | -- | $1.9K | -$0.20 | -- | -- |
12/31/2015 | Q4 | -- | -$480 | $0.03 | -- | -- |
09/30/2015 | Q3 | -- | $5.7K | -$0.45 | -- | -- |
ProMIS Neurosciences reported -- worth of top line sales in its most recent quarter.
ProMIS Neurosciences announced earnings per share of -$0.21 which represents a miss of analyst forecast a -- per share.
ProMIS Neurosciences reported -- that represents -- per share over the last quarter.
ProMIS Neurosciences's earnings are forecast to grow from $0.11 per share to -- per share next year representing an increase of --.
ProMIS Neurosciences's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.